Literature DB >> 23996141

Ductal carcinoma in situ: knowledge of associated risks and prognosis among Latina and non-Latina white women.

Aparna R Parikh1, Celia Patricia Kaplan, Nancy J Burke, Jennifer Livaudais-Toman, E Shelley Hwang, Leah S Karliner.   

Abstract

While not itself life-threatening, ductal carcinoma in situ (DCIS) can progress to invasive disease if untreated, and confers an increased risk of future breast cancer. We investigated knowledge of DCIS among a cohort of English- and Spanish-speaking Latina and English-speaking non-Latina white women previously treated for DCIS. We examined knowledge of DCIS with four true/false statements about risk of invasive disease, breast cancer recurrence, and prognosis. For each knowledge statement, we modeled the odds of a correct answer by language-ethnicity (English-speaking Latinas, Spanish-speaking Latinas, and English-speaking whites) adjusting for demographics, health history, and treatment factors. Of 710 participants, 52 % were English-speaking whites, 21 % English-speaking Latinas, and 27 % Spanish-speaking Latinas. Less than half (41 %) of participants were aware that DCIS is not life-threatening and only 32 % knew that surgical treatment choice does not impact mortality; whereas two-thirds (67 %) understood that DCIS confers increased risk of future breast cancer, and almost all (92 %) knew that DCIS, if untreated, could become invasive. Only three Spanish-speakers used professional interpreters during discussions with their physicians. In adjusted analyses, compared to English-speaking whites, both English- and Spanish-speaking Latinas had significantly lower odds of knowing that DCIS was not life-threatening (OR, 95 % CI 0.6, 0.4-0.9 and 0.5, 0.3-0.9, respectively). In contrast, Spanish-speaking Latinas had a twofold higher odds of knowing that DCIS increases risk of future breast cancer (OR, 95 % CI 2.6, 1.6-4.4), but English-speaking Latinas were no different from English-speaking whites. Our data suggest that physicians are more successful at conveying the risks conferred by DCIS than the nuances of DCIS as a non-life-threatening diagnosis. This uneven communication is most marked for Spanish-speaking Latinas. In addition to the use of professional interpreters, efforts to create culturally and linguistically standardized information could improve knowledge and engagement in informed decision making for all DCIS patients.

Entities:  

Mesh:

Year:  2013        PMID: 23996141      PMCID: PMC4520413          DOI: 10.1007/s10549-013-2676-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.624


  23 in total

1.  Challenges in ductal carcinoma in situ risk communication and decision-making: report from an American Cancer Society and National Cancer Institute workshop.

Authors:  Ann H Partridge; Joann G Elmore; Debbie Saslow; Worta McCaskill-Stevens; Stuart J Schnitt
Journal:  CA Cancer J Clin       Date:  2012-04-04       Impact factor: 508.702

2.  Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.

Authors:  Nina Bijker; Philip Meijnen; Johannes L Peterse; Jan Bogaerts; Irène Van Hoorebeeck; Jean-Pierre Julien; Massimiliano Gennaro; Philippe Rouanet; Antoine Avril; Ian S Fentiman; Harry Bartelink; Emiel J Th Rutgers
Journal:  J Clin Oncol       Date:  2006-06-26       Impact factor: 44.544

3.  Language barriers and patient-centered breast cancer care.

Authors:  Leah S Karliner; E Shelley Hwang; Dana Nickleach; Celia P Kaplan
Journal:  Patient Educ Couns       Date:  2010-08-03

4.  Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.

Authors:  E R Fisher; J Dignam; E Tan-Chiu; J Costantino; B Fisher; S Paik; N Wolmark
Journal:  Cancer       Date:  1999-08-01       Impact factor: 6.860

Review 5.  The natural history of ductal carcinoma in situ of the breast: a review.

Authors:  Bircan Erbas; Elena Provenzano; Jane Armes; Dorota Gertig
Journal:  Breast Cancer Res Treat       Date:  2005-12-01       Impact factor: 4.872

6.  Knowledge, satisfaction with information, decisional conflict and psychological morbidity amongst women diagnosed with ductal carcinoma in situ (DCIS).

Authors:  Simone De Morgan; Sally Redman; Catherine D'Este; Kris Rogers
Journal:  Patient Educ Couns       Date:  2010-08-09

7.  Doctor-patient communication patterns in breast cancer adjuvant therapy discussions.

Authors:  Laura A. Siminoff; Peter Ravdin; Natalie Colabianchi; Christina M. Saunders Sturm
Journal:  Health Expect       Date:  2000-03       Impact factor: 3.377

Review 8.  Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.

Authors:  Beth A Virnig; Todd M Tuttle; Tatyana Shamliyan; Robert L Kane
Journal:  J Natl Cancer Inst       Date:  2010-01-13       Impact factor: 13.506

Review 9.  Noninvasive breast cancer.

Authors:  M Rebner; U Raju
Journal:  Radiology       Date:  1994-03       Impact factor: 11.105

10.  Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.

Authors:  Karla Kerlikowske; Annette Molinaro; Imok Cha; Britt-Marie Ljung; Virginia L Ernster; Kim Stewart; Karen Chew; Dan H Moore; Fred Waldman
Journal:  J Natl Cancer Inst       Date:  2003-11-19       Impact factor: 13.506

View more
  4 in total

Review 1.  Patient-Driven Second Opinions in Oncology: A Systematic Review.

Authors:  Marij A Hillen; Niki M Medendorp; Joost G Daams; Ellen M A Smets
Journal:  Oncologist       Date:  2017-06-12

2.  "Is it cancer or not?" A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ.

Authors:  Shoshana M Rosenberg; Jennifer M Gierisch; Anna C Revette; Carol L Lowenstein; Elizabeth S Frank; Deborah E Collyar; Thomas Lynch; Alastair M Thompson; Ann H Partridge; E Shelley Hwang
Journal:  Cancer       Date:  2022-02-22       Impact factor: 6.921

Review 3.  Interventions are needed to support patient-provider decision-making for DCIS: a scoping review.

Authors:  Claire Kim; Laurel Liang; Frances C Wright; Nicole J Look Hong; Gary Groot; Lucy Helyer; Pamela Meiers; May Lynn Quan; Robin Urquhart; Rebecca Warburton; Anna R Gagliardi
Journal:  Breast Cancer Res Treat       Date:  2017-12-23       Impact factor: 4.872

4.  Ductal carcinoma in situ (DCIS): The importance of patient-reported outcomes (PRO).

Authors:  Laura S Dominici; Shoshana M Rosenberg
Journal:  Curr Breast Cancer Rep       Date:  2020-04-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.